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The potential application of biochemically modiﬁed electrodes was investigated for construction of a
drug biosensor. The electrocatalytic response of lidocaine was examined through modiﬁed electrodes using
the electron transfer ability of hemoglobin (Hb) immobilized on gold ﬁlm modiﬁed with a self-assembled
monolayer (SAM) of 3-mercaptopropionic acid (MPA). According to the results of voltammetric studies,
Au/MPA/Hb electrodes exhibited high sensitivity and good electrocatalytic activity for the reduction of
lidocaine, motivating us to construct drug biosensors. With this study, a new electroanalytical procedure
is proposed for the determination of lidocaine level in medical applications or therapeutic formulations
containing lidocaine as the active ingredient.
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Introduction
Local anesthetics work in general by binding to sodium channel receptors inside the nerve, and thereby
preventing depolarization of nerve cells by binding to cell membrane voltage-dependent sodium channels and
inhibiting the passage of sodium ions, thus blocking the action potential and neural conduction. 1 Local
anesthetic molecules are composed of 3 parts: an aromatic group, an intermediate ester or amide chain, and a
secondary or tertiary amino terminus. 2 The aromatic portion of the molecule is responsible for the lipophilic or
more accurately hydrophobic properties of the molecule, whereas the amine end confers water solubility. Lipid
solubility is essential for the penetration of the nerve. The greater lipid solubility enhances diﬀusion through
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nerve sheaths, as well as the neural membranes of axons. 3 The intermediate chain provides the separation
between the hydrophilic and hydrophobic ends of the molecule. Activity of local anesthetics depends on their
lipid solubility, diﬀusibility, aﬃnity for protein binding, percent ionization at physiological pH approximately,
and vasodilating properties. Local anesthetics reversibly block nerve conduction when applied to nerve tissue at
appropriate concentrations. 4 However, the toxicity of these drugs seems to constitute the main obstacle to their
medical uses. Many side eﬀects, particularly cardiovascular and neurological, may occur in the case of increasing
toxicity. Lidocaine is one of the most commonly used local anesthetics and peripheral analgesics in surgery, 5
gynecology, 6 and dentistry. 7 It may have some serious side eﬀects on cardiovascular systems, like ventricular
arrhythmia in the case of overdosed intake. In adequate concentrations of 0.5%-2%, lidocaine produces a rapid
onset of intense motor and sensory nerve blockade. 8 Higher concentrations were used for spinal anesthesia, until
reports of transient radicular irritation suggested that these concentrations may be also neurotoxic. 9 This is
because the quantitative determination of local anesthetics in blood and other biological materials is obviously
around the considerable point in assessment of toxicity, metabolism, and distribution of these drugs following
various routes of administration. 10,11
Various approaches, such as ﬂow-injection analysis,12 high-performance liquid chromatography (HPLC),13,14
and gas chromatography (GC) combined with mass spectrophotometric 15 and ultraviolet (UV) spectroscopic
detectors, 16 have been developed for the determination of anesthetic drugs and their metabolites in pharmaceutical preparations as well as in biological samples. Although these methods are speciﬁc and highly sensitive, they
require complex controlling systems for temperature and vacuum that makes the methods expensive. Separation
processes and sample preparation are also diﬃcult in these systems, so that electrochemical methods have been
found to be cheaper/faster alternative techniques. 17 So far, a few applications of lidocaine determination in electrochemistry have been reported. Kulapina and Barinova developed ion selective electrodes sensitive towards a
group of nitrogen-containing drugs, including lidocaine. 18,19 They used tetraphenyl borate (TPB) as the counterion in electrode-active components of ion selective electrodes for the potentiometric determination of drugs.
Halbert and Baldwin used glassy carbon electrodes for the electrochemical detection of lidocaine and its metabolites in blood serum after separation by liquid chromatography. 20 Sun and colleagues developed a method for
simultaneous determination of lidocaine, proline, and lomeﬂoxacin in urine samples by capillary electrophoresis21
electrochemiluminescence detection with Ru(bpy) 2+
Under optimized conditions, satisfactory results such as
3 .

high sensitivity, good linearity, and reproducibility were obtained. 21 Solid-state electrochemiluminescence detectors that employ tris(2,2  -bipyridyl)ruthenium(II) (Ru(bpy) 2+
3 )-Zirconia–Naﬁon composite modiﬁed glassy
carbon disk electrodes and microchips have been used to detect pharmaceuticals such as tramadol, lidocaine,
and oﬂoxacin. 22 The detection limit for lidocaine was found to be 5.0 × 10 −6 mol L −1 . As all these methods
are complex, it is of great importance to develop a new rapid, simple, and sensitive method for the quantitative
determination of lidocaine. Thus, modifying the electrode surfaces has been considered a very eﬀective approach
to achieve these speciﬁcations. In this sense, Oliveira et al. recently developed a new electroanalytical method,
based on cyclic voltammetry and square wave voltammetry techniques with boron-doped diamond electrodes
as working electrodes, for lidocaine determination in pharmaceutical preparation. 23 Another group immobilized cytochrome P450 2B6 (CYP2B6) on zirconium dioxide nanoparticles (ZrO 2 ) that incorporated colloidal
platinum and poly-lysine on glassy carbon electrodes. The ﬁlm has shown good electrocatalytic behavior on
reduction of lidocaine. 24
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We modiﬁed gold electrodes with a self-assembled monolayer (SAM) and immobilized the redox protein
hemoglobin (Hb) on these surfaces in order to perform lidocaine analysis by depending on the electroactive
character of the protein. It is well established that direct electron transfer of redox proteins on electrode surfaces
serve as a model to understand electron transfer mechanism in biological systems and fabricate bioelectronic
devices and electrochemical biosensors. 25 Among the electroactive proteins, Hb is an ideal molecule recently
used in electrocatalysis and biosensor development. 26 However, it is usually diﬃcult for the redox proteins to
transfer electrons directly at naked solid electrodes because redox centers are deeply buried inside hemoglobin
and adsorption of the protein at solid surfaces leads to conformational variations and loss of activity. 27,28 In
addition, the absorption of Hb on the electrode surface such as platinum and glassy carbon may result in the
denaturation and thus loss of its electrochemical activities and bioactivities. 29−32 Gold could be an alternative
substrate for stable immobilization of biomolecules without aﬀecting their bioactivity. 33 Moreover, electron
transfer between redox proteins and electron surfaces is facilitated. This is induced by many factors, such as
high surface-to-volume ratio, high surface energy, and decreased proteins-metal particles distance, as well as the
acting as electron conducting pathways between prosthetic groups and the electrode surface from the gold. 34
In order to obtain the direct electrochemistry of the heme protein on the basis of biosensors, using electrodes
modiﬁed with functional nanomaterials, 27 self-assembled monolayers, 35 polymer ﬁlms, 36 or surfactants, 37 has
attracted great eﬀorts. These surfaces have been widely used in the electrocatalysis of hydrogen peroxide, 26
nitric oxide, 38 trichloroacetic acid, 36 and some drugs 39 due to the enzymatic activity of Hb. In this work, the
electrochemical behavior of Au/MPA/Hb electrodes was studied by adsorbing Hb on gold electrodes modiﬁed
with 3-mercaptopropionic acid (MPA). The electrocatalytic response to the local anesthetic drug lidocaine was
analyzed via Au/MPA/Hb electrodes.

Materials and methods
Reagents
Bovine hemoglobin, MPA (99%) and lidocaine (98%) were purchased from Sigma. All the other chemicals were
of analytical grade. A 100 mM phosphate buﬀer solution (PBS, pH 7.0) was prepared from NaH 2 PO 4 · 2H 2 O
(Aldrich) and Na 2 HPO 4 · 2H 2 O (Aldrich). A 10 mM MPA solution was prepared with absolute ethanol and 20
mg/mL Hb solutions were prepared freshly at PBS pH 7.0 and stored at 4 ◦ C. Stock solution of lidocaine was
prepared by dissolving lidocaine in ethanol (0.23 g/mL) and then diluting 100 μL of this stock solution in 10
mL of PBS to get a ﬁnal concentration of 10 mM, pH 7.0. Stock solution preparation can also be found in the
literature. 40

Electrode preparation
Au/MPA electrode preparation
The gold electrode was polished with 0.1 and 0.05 μM alumina powder and cleaned in a mixture of absolute
ethanol and distilled water. Then the electrode was electrochemically pretreated by cycling the potential from
+0.2 V to +1.6 V vs. the saturated calomel reference electrode (SCE) in 1 M H 2 SO 4 , until reproducible
voltammograms were obtained. The electrode was rinsed and immersed in 10 mM MPA solution for 30 min.
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The resulting electrode was then washed with absolute ethanol followed by a wash step in triple distilled water
to remove physically adsorbed thiol molecules. This electrode was named as the Au/MPA electrode.
Au/MPA/Hb electrode preparation
Five microliters of Hb solution (20 mg/mL) was cast on the surface of the Au/MPA electrode and allowed to
dry at 4 ◦ C overnight. Finally, the electrodes were washed with PBS and denoted as Au/MPA/Hb electrodes.

Electrochemical measurements
All electrochemical measurements were performed with a CHI 660C (USA) model electrochemical workstation.
In this study, a conventional 3-electrode system was used with a ﬁlm modiﬁed or bare gold disk electrode with
an area of 0.0314 cm 2 , SCE, and a platinum wire as counter electrode. Voltammetry on modiﬁed electrodes
was performed in buﬀer solutions purged with nitrogen gas prior to the experiments.

Results and discussion
A quantitative understanding of the redox proﬁle of the drugs is important to obtain knowledge about their
toxicological mechanisms and for design of new analytical assays. 40 In this manner, the electrochemical behavior
of lidocaine at physiological pH on biochemically modiﬁed electrodes is important for the advance of knowledge of
molecular toxicological mechanism of this drug and the development of new analytical assays for the quantitative
determination in biological systems and pharmaceutical formulations. Figure 1 shows the chemical structure of
lidocaine. As can be seen, it is an amide-derivate of diethylamino acetic acid.
As mentioned, it is aimed to get Au/MPA/Hb surfaces. Gold surfaces have been used as suitable
candidates for modifying electrodes utilizing Au-S bonds due to alkanethiol covalent binding to the surface. 41
The gold surface also allows the enhancement of direct electron transfer between redox biomolecules and
electrode surfaces, providing faster and more eﬀective processes based on charge transfer. Direct electron
transfer of immobilized Hb on the SAM modiﬁed gold electrode was facilitated due to the suitable interfacial
property of the alkanethiol molecule. Electrostatic attraction between the negatively charged –COOH terminal
group of MPA and the positively charged iron in the heme group of protein was considered to provide the
necessary scaﬀold background for the protein to be adsorbed at optimal distance and in correct orientation. 42,43
The electrochemical behavior of the fabricated electrodes was examined in order to control the direct electron
transfer of Hb. Cyclic voltammetry was performed vs. SCE in PBS pH 7.0 between –0.4 V and 0.0 V.
As depicted in Figure 2a, the Au/MPA/Hb electrode showed well deﬁned redox peaks at –0.15 V (Ep a )
and –0.33 V (Ep c ) in a solution of PBS. This result denotes the characteristic Fe(III)/Fe(II) redox couple of
heme protein indicating direct electron transfer between Hb and electrode. In similar test conditions, the cyclic
voltammogram obtained with only the Au/MPA electrode (Figure 2b) shows no redox peaks in the potential
range. These results exhibited the electrochemical behavior of Hb on Au/MPA electrodes. Hence, Au/MPA/Hb
was considered to be usable as a working electrode for investigation of the electrochemical behavior of lidocaine
and determination of the drug by using cyclic voltammetry (CV) and diﬀerential pulse voltammetry (DPV) in
aqueous solutions of lidocaine.
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Figure 1. Chemical structure of lidocaine.

Figure 2. Cyclic voltammograms in PBS pH 7.0 at 0.1
V/s of (a) Au/MPA/Hb electrode and (b) Au/MPA electrode.

Figure 3 illustrates the cyclic voltammograms obtained in the presence and absence of lidocaine in PBS,
respectively. Voltammetric behavior shown in Figure 3a indicates an irreversible peak at +1.53 V, due to the
oxidation of lidocaine on the Au/MPA/Hb electrode at pH 7.0 PBS. This is in agreement with results reported
in the literature. 23
DPV has been applied as a sensitive analytical method for determination of sub-micromolar levels of
organic compounds. 44 Figure 4 shows typical DPVs of 10 mM lidocaine in PBS pH 7.0 at diﬀerent electrodes.
At bare Au (Figure 4a) and Au/MPA (Figure 4b) electrodes, oxidation peak currents of lidocaine were relatively
weak, with peak potential of +1.6 V and +1.5 V, respectively. In contrast, the Au/MPA/Hb electrode showed
enhanced signals at +1.53 V leading to better electroactivity on the response of lidocaine. This indicated that
Hb exhibits an electrocatalytic eﬀect on the oxidation of the drug. 45
DPVs for solutions containing various concentrations of lidocaine with the Au/MPA/Hb electrode are
shown in Figure 5. The obtained voltammograms illustrate that the peak current increased with lidocaine
concentration in a dynamic range from 5 × 10 −7 M to 2.9 × 10 −6 M, with a regression equation of i p =
2.531C + 5.775 (i p in μA and C in μM) (Figure 6). In our studies, the detection limit was obtained at
2.9 × 10 −7 M, which is lower than the 5.0 × 10 −6 mol L −1 detected on a tris(2,2  -bipyridyl)ruthenium(II)
22
(Ru(bpy) 2+
and comparable with the detection
3 )–zirconia–naﬁon composite modiﬁed glassy carbon electrode

limit obtained with a boron-doped diamond electrode. 23 The sensitive and fast catalytic response of the Hb
electrode may be attributed to the good direct electrochemistry of Hb immobilized on Au/MPA. The stability
of the ﬁlm was examined by storing the electrodes in PBS at 4 ◦ C for 7 days, and it was found that the electrode
almost retained its initial activity during this time.
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Figure 3. Cyclic voltammograms of Au/MPA/Hb elec-

Figure 4. Diﬀerential pulse voltammograms of 10 mM

trode in (a) lidocaine 10 mM in PBS, pH 7.0, (b) PBS, pH

lidocaine in PBS pH 7.0 at diﬀerent electrodes: (a) Au,

7.0. Scan rate 0.1 V/s.

(b) Au/MPA, and (c) Au/MPA/Hb electrode. Pulse amplitude 50 mV, pulse width 50 ms.
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Figure 6. Calibration curve for lidocaine concentrations.

creasing concentrations of lidocaine at pH 7.0 PBS on
Au/MPA/Hb electrode: pulse amplitude, 50 mV, pulse
width, 50 ms. Lidocaine concentration (1) 4.99 × 10 −7
M, (2) 9.90 × 10 −7 M, (3) 1.96 × 10 −6 M, (4) 2.91 ×
10 −6 M, and (5) 1.33 × 10 −5 M.

Conclusion
Modern electrochemical methods are now sensitive, selective, rapid and easy. These techniques are applicable to
analysis in pharmaceutical ﬁelds and most areas of analytical chemistry. They are probably the most versatile
of all types of trace pharmaceutically active compound analysis. Voltammetric techniques have also been
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extremely useful in measuring blood levels, metabolites, and urinary excretion of drugs following low doses,
especially when coupled with chromatographic methods. 46 In recent years, biomolecule-based electroanalysis
methods have often been used for monitoring concentrations of analytes. Biomolecule-based analytic systems
can meet the needs for real-time monitoring and replace the time consuming analytical techniques used in
industrial and clinical chemistry and medicine.
In the present study, heme protein-based biosensor mechanism is studied by using chemically modiﬁed
electrodes by means of coupled hemoglobin to Au/MPA composite. After the electrochemical studies, it is
concluded that lidocaine, one of the most widely used local anesthetics, has an oxidative peak when cyclic
and diﬀerential pulse voltammetry experiments were conducted using Au/MPA/Hb electrodes. It was clearly
demonstrated that the Au/MPA/Hb acted as an eﬃcient promoter to enhance electrochemical response of
lidocaine. The electrochemical performance of the modiﬁed electrode on lidocaine is comparable with the
other techniques used in the literature but it is cheaper and easier to perform, providing a new promising
electrochemical sensing platform to determine trace amounts of lidocaine successfully in tissue and blood samples
as well as pharmaceutical formulations.
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